切换至 "中华医学电子期刊资源库"
高级检索
中华实验和临床感染病杂志(电子版)

中华实验和临床感染病杂志(电子版) ›› 2024, Vol. 18 ›› Issue (01) : 49 -53. doi: 10.3877/cma.j.issn.1674-1358.2024.01.008

病例报告

结核性脑膜炎并发矛盾反应一例
陈艳1, 侍效春2,†(), 刘晓清3   
  1. 1. 100730　北京，中国医学科学院北京协和医学院，北京协和医院，疑难重症及罕见病国家重点实验室，感染内科
    2. 100730　北京，中国医学科学院北京协和医学院，北京协和医院，疑难重症及罕见病国家重点实验室，感染内科；100730　北京，中国医学科学院北京协和医学院，结核病研究中心
    3. 100730　北京，中国医学科学院北京协和医学院，北京协和医院，疑难重症及罕见病国家重点实验室，感染内科；100730　北京，中国医学科学院北京协和医学院，结核病研究中心；100730　北京，中国医学科学院北京协和医学院，国际临床流行病学网，临床流行病学教研室
  • 收稿日期:2023-07-13 出版日期:2024-02-15
  • 通信作者: 侍效春
  • 基金资助:
    中央高水平医院临床科研专项(No. 2022-PUMCH-A-043)

A case of tuberculous meningitis complicated with paradoxical reaction

Yan Chen1, Xiaochun Shi2,†(), Xiaoqing Liu3   

  1. 1. Division of Infectious Diseases, Department of Internal Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Unison Medical College, Beijing 100730, China
    2. Division of Infectious Diseases, Department of Internal Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Unison Medical College, Beijing 100730, China; Centre for Tuberculosis Research, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
    3. Division of Infectious Diseases, Department of Internal Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Unison Medical College, Beijing 100730, China; Centre for Tuberculosis Research, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China; Clinical Epidemiology Unit, Peking Union Medical College, International Clinical Epidemiology Network, Beijing 100730, China
  • Received:2023-07-13 Published:2024-02-15
  • Corresponding author: Xiaochun Shi
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

陈艳, 侍效春, 刘晓清. 结核性脑膜炎并发矛盾反应一例[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(01): 49-53.

Yan Chen, Xiaochun Shi, Xiaoqing Liu. A case of tuberculous meningitis complicated with paradoxical reaction[J/OL]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2024, 18(01): 49-53.

目的

分析1例结核性脑膜炎并发矛盾反应患者的临床特征，以提升临床对结核性脑膜炎并发矛盾反应的关注度。

方法

回顾性分析中国医学科学院北京协和医院2020年9月8日收治的1例结核性脑膜炎并发矛盾反应患者的临床资料、诊疗经过和预后。

结果

该患者以发热、头痛起病，脑脊液检查提示颅压明显升高，白细胞总数、蛋白水平高，氯化物水平降低，脑脊液及外周血结核分枝杆菌感染T细胞检测阳性，头颅核磁共振提示多发异常信号，其余病原学检查均为阴性，考虑结核性脑膜炎可能性大，予诊断性抗结核治疗，临床症状和脑脊液指标一度好转，糖皮质激素减量后病情再度恶化，经系统检查除外其他感染后，考虑矛盾反应，糖皮质激素再次加量后好转。出院后1年复查头颅核磁共振未见明显异常。

结论

结核性脑膜炎并发矛盾反应的病例临床较少见，易漏诊、误诊而延误治疗。对抗结核治疗启动后反而出现病情加重者应警惕并发矛盾反应，治疗首选糖皮质激素。

关键词: 结核性脑膜炎, 矛盾反应, 治疗
Objective

To analyze a case with tuberculous meningitis complicated with paradoxical reaction, and to raise the attention to tuberculous meningitis complicated with paradoxical reaction.

Methods

The clinical data, diagnosis and treatment process and prognosis of a patient with tuberculous meningitis complicated with paradoxical reaction admitted to Peking Union Medical College Hospital, Chinese Academy of Medical Sciences on September 8th 2020 were analyzed, retrospectively.

Results

The patient presented clinically with headache and fever, the cerebrospinal fluid examination showed that the intracranial pressure was significantly increased, the white blood cells and protein level were high, and the chlorine level was low. Mycobacterium tuberculosis infection of T cells spot test were positive both in peripheral blood and cerebrospinal fluid, brain Magnetic Resonance Imaging (MRI) showed multiple abnormal signals, while the rest of the etiological examination was negative. The patient was considered tuberculous meningitis and started diagnostic anti-tuberculosis treatment. The clinical symptoms and cerebrospinal fluid tests improved for a while, but the condition deteriorated again after the reduction of glucocorticoids. The patient was considered paradoxical reaction. After increased doses of glucocorticoid, the patient improved rapidly. MRI at 1 year was essentially unremarkable.

Conclusions

Tuberculous meningitis complicated with paradoxical reaction is rare, which is easy to be misdiagnosed and delayed to receive treatment. Therefore, clinicians are reminded to be alert to tuberculous meningitis complicated by paradoxical reaction for patient with aggravation of the disease after anti-tuberculosis treatment, high-dose glucocorticoids is the preferred treatment.

Key words: Tuberculous meningitis, Paradoxical reaction, Treatment
图1 本病例治疗前后头颅核磁共振影像学注：A：2020年9月10日患者头颅核磁共振示基底节区异常信号；B：2020年10月21日患者头颅核磁共振示基底节区大片异常信号；C：2020年11月26日患者头颅核磁共振示病变范围明显缩小
表1 本病例住院期间脑脊液化验结果和治疗
日期 压力（mmH2O） 白细胞总数（× 106/L） 单核细胞数（× 106/L） 多核细胞数（× 106/L） 葡萄糖（mmol/L） 氯化物（mmol/L） 蛋白（g/L） 治疗
2020年9月9日 320 60 46 4 2.2 117 1.59 HRZE，地塞米松5 mg/次、1次/d
2020年9月16日 210 60 48 12 2.3 123 1.28 HRZE +利奈唑胺，地塞米松5 mg/次、1次/d
2020年9月23日 210 36 34 2 2.6 122 1.09 HRZE +利奈唑胺，地塞米松5 mg/次、1次/d
2020年9月30日 275* 42 40 2 2.4 121 1.02 HRZE +利奈唑胺，地塞米松5 mg/次、1次/d
2020年10月13日 230* 72 66 6 2.4 122 1.39 HRZE +利奈唑胺，泼尼松20 mg/次、1次/d
2020年10月20日 250* 146 130 16 2.0 121 2.44 HRZE +利奈唑胺，泼尼松15 mg/次、1次/d
2020年10月27日 > 330* 136 109 27 2.2 123 2.07 HRZE +利奈唑胺，地塞米松5 mg/次、1次/d
2020年11月3日 260* 156 126 30 1.7 122 2.04 HRZE +利奈唑胺，地塞米松5 mg/次、1次/d
2020年11月16日 220* 44 42 2 1.9 122 1.12 HRZE，地塞米松5 mg/次、1次/d
2020年11月30日 265 30 28 2 2.2 123 0.80 HRZE，泼尼松30 mg/次、1次/d
[1]
Donovan J, Figaji A, Imran D, et al. The neurocritical care of tuberculous meningitis[J]. Lancet Neurol, 2019,18(8):771-783.
[2]
中华医学会结核病学分会结核性脑膜炎专业委员会. 2019中国中枢神经系统结核病诊疗指南[J]. 中华传染病杂志,2020,38(7):400-408.
[3]
Organization WH (2021). Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic[EB/OL]. 2021.

URL    
[4]
Organization WH (2019). World Health Statistics 2019: Monitoring health for the SDGs, sustainable development goals[EB/OL]. 2019.

URL    
[5]
Schaller MA, Wicke F, Foerch C, et al. Central nervous system tuberculosis: etiology, clinical manifestations and neuroradiological features[J]. Clin Neuroradiol,2019,29(1):3-18.
[6]
Navarro-Flores A, Fernandez-Chinguel JE, Pacheco-Barrios N, et al. Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis[J]. J Neurol, 2022,269(7):3482-3494.
[7]
Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2018[EB/OL]. 2019.

URL    
[8]
Pang Y, An J, Shu W, et al. Epidemiology of extrapulmonary tuberculosis among inpatients, China. 2008-2017[J]. Emerg Infect Dis,2019,25(3):457-464.
[9]
Basu Roy R, Thee S, Blázquez-Gamero D, et al. Performance of immune-based and microbiological tests in children with tuberculosis meningitis in Europe: a multicentre Paediatric Tuberculosis Network European Trials Group (ptbnet) study[J]. Eur Respir J,2020,56(1):1902004.
[10]
Thwaites GE, Chau TT, Farrar JJ. Improving the bacteriological diagnosis of tuberculous meningitis[J]. J Clin Microbiol, 2004,42(1):378-379.
[11]
Erdem H, Ozturk-Engin D, Elaldi N, et al. The microbiological diagnosis of tuberculous meningitis of Haydarpasa-1 study[J]. Clin Microbiol Infect,2014,20(10):O600-O608.
[12]
Kennedy DH, Fallon RJ. Tuberculous meningitis[J]. JAMA,1979, 241(3):264-268.
[13]
Hernandez AV, Laurentis L, Souza I, et al. Diagnostic accuracy of Xpert MTB/RIF for tuberculous meningitis: systematic review and meta-analysis[J]. Trop Med Int Health,2021,26(2):122-132.
[14]
Donovan J, Cresswell FV, Thuong NTT, et al. Xpert MTB/RIF ultra for the diagnosis of tuberculous meningitis: A small step forward[J]. Clin Infect Dis,2020,71(8):2002-2005.
[15]
Chen Y, Wang Y, Liu X, et al. Comparative diagnostic utility of metagenomic next-generation sequencing, GeneXpert, modified Ziehl-Neelsen staining, and culture using cerebrospinal fluid for tuberculous meningitis: A multi-center, retrospective study in China[J]. J Clin Lab Anal,2022,36(4):e24307.
[16]
Ramachandran PS, Ramesh A, Creswell FV, et al. Integrating central nervous system metagenomics and host response for diagnosis of tuberculosis meningitis and its mimics[J]. Nat Commun,2022,13(1):1675.
[17]
Wilson MR, Sample HA, Zorn KC, et al. Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis[J]. N Engl J Med,2019,380(24):2327-2340.
[18]
林爱清, 张璐, 成宝涛, 等. 二代测序技术应用于脑脊液检测在结核性脑膜炎中的早期诊断价值[J/CD]. 中华实验和临床感染病杂志(电子版),2020,14(4):291-295.
[19]
Arai M, Inaba R. A case of tuberculous meningitis with pleural effusion as a manifestation of a paradoxical reaction during anti-tuberculosis therapy[J]. Rinsho Shinkeigaku,2019,59(8):541-544．
[20]
Pepper DJ, Marais S, Maartens G, et al. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series[J]. Clin Infect Dis,2009,48(11): e96-e107.
[21]
徐勇胜. 结核病治疗中的矛盾反应[J]. 中华实用儿科临床杂志,2019,34(9):646-649.
[22]
Liu Y, Wang Z, Yao G, et al. Paradoxical reaction in HIV-negative tuberculous meningitis patients with spinal involvement[J]. Int J Infect Dis,2019,79:104-108．
[23]
Nahid P, Dorman SE, Alipanah N, et al. Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis[J]. Clin Infect Dis,2016,63(7):e147-e195.
[24]
Lee JY. Diagnosis and treatment of extrapulmonary tuberculosis[J]. Tuberc Respir Dis (Seoul),2015,78(2):47-55.
[25]
Ravimohan S, Tamuhla N, Nfanyana K, et al. Robust reconstitution of tuberculosis-specifc polyfunctional CD4+ T-cell responses and rising systemic interleukin 6 in paradoxical tuberculosis-associated immune reconstitution infammatory syndrome[J]. Clin Infect Dis,2016,62(6):795-803.
[26]
中华医学会结核病学分会. 结核病免疫治疗专家共识(2022年版)[J]. 中华结核和呼吸杂志,2022,45(7):651-666.
[27]
Armange L, Lacroix A, Petitgas P, et al. The use of TNF-α antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review[J]. Eur J Clin Microbiol Infect Dis,2023,42(4):413-422.
[28]
Abo YN, Curtis N, Osowicki J, et al. Infliximab for paradoxical reactions in pediatric central nervous system tuberculosis[J]. J Pediatric Infect Dis Soc,2021,10(12):1087-1091.
[29]
Marais BJ, Cheong E, Fernando S, et al. Use of infliximab to treat paradoxical tuberculous meningitis reactions[J]. Open Forum Infect Dis,2020,8(1):ofaa604.
[30]
Garg RK, Malhotra HS, Kumar N. Paradoxical reaction in HIV negative tuberculous meningitis[J]. J Neurol Sci,2014,340(1-2):26-36.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(08): 778-784.
[2] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[3] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[4] 易柏成, 李旭光, 王容容, 王新璇. 数字化3D打印导板应用于上前牙钙化根管治疗2例[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 385-390.
[5] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[6] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[7] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[8] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[9] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[10] 袁园园, 岳乐淇, 张华兴, 武艳, 李全海. 间充质干细胞在呼吸系统疾病模型中肺组织分布及治疗机制的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 374-381.
[11] 陈杰, 武明胜, 李一金, 李虎, 向源楚, 荣新奇, 彭健. 低位直肠癌冷冻治疗临床初步分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 494-498.
[12] 国文凯, 纪鹏程, 毕靖茹, 谢院生. IgA 肾病的十种治疗措施[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 327-333.
[13] 帖璇, 苏晓乐, 王利华. 抗中性粒细胞胞质抗体相关性血管炎治疗研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 345-351.
[14] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[15] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号

AI
小
编
AI小编
你好！我是《中华医学电子期刊资源库》AI小编，有什么可以帮您的吗？